Finance

Lists
QNTM:NASDAQ
Quantum Biopharma Ltd
3,14 USD
0,00%
(0,00) 1D
3,11 USD
-1,11% (-0,035)
Pre-market
Closed: 7-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNTM...
Mkt. cap
25,88 млн
Avg. vol.
190,99 миң
Volume
886,00
52-wk high
16,36 USD
52-wk low
2,07 USD
EPS
-5,70 USD
Beta
0,39
Shares outstanding
8,09 млн
No. of employees
17
Mkt. cap
25,88 млн
Avg. vol.
190,99 миң
Volume
886,00
52-wk high
16,36 USD
52-wk low
2,07 USD
EPS
-5,70 USD
Beta
0,39
Shares outstanding
8,09 млн
No. of employees
17
News stories
From web sources and news partners
About Quantum Biopharma Ltd
CEO-
Employees17
Founded1994
Headquarters-
SectorPharmaceutical industry
Websitequantumbiopharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to QNTM in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for QNTM in the last 3 months
Highest
Current 3,14 USD
8,00 USD (+154,37%)
Average
8,00 USD (+154,37%)
Lowest
8,00 USD (+154,37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael King
Rodman & Renshaw
Buy
Initiated
8,00 USD
+154,4%
08/31/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
495,22 миң
70,40 миң
626,09 миң
387,43 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,04 млн
1,37 млн
1,32 млн
1,76 млн
Operating expense
4,68 млн
2,37 млн
2,97 млн
2,29 млн
Total operating expenses
4,68 млн
2,37 млн
2,97 млн
2,29 млн
Operating income
-4,68 млн
-2,37 млн
-2,97 млн
-2,29 млн
Other non operating income
-222,38 миң
-2,48 млн
-10,47 млн
-972,01 миң
EBT including unusual items
-4,75 млн
-3,70 млн
-13,75 млн
-3,09 млн
EBT excluding unusual items
-4,91 млн
-6,29 млн
-13,48 млн
-3,50 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,32 млн
-3,03 млн
-13,56 млн
-3,25 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
100,42 миң
-
-
-
Interest expense
-105,08 миң
-1,44 млн
-45,18 миң
-239,16 миң
Net interest expenses
-4,66 миң
-1,44 млн
-45,18 миң
-239,16 миң
Depreciation and amortization charges
145,34 миң
129,37 миң
127,44 миң
128,37 миң
EBITDA
-4,53 млн
-2,24 млн
-2,84 млн
-2,17 млн
Gain or loss from assets sale
-
117,14 миң
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору